Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Teladoc One is a model of care delivered as a single, predictive and adaptive experience to drive better health outcomes and address the rising total cost of care Multidisciplinary care teams, paired...
-
Gentherm reports record Q2 2026 revenue, raises full-year guidance, announces $400M stock repurchase program, and expands medical portfolio.
-
NEW YORK, July 23, 2026 (GLOBE NEWSWIRE) -- Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions, today announced the launch of Medidata Plus. This clinical...
-
Transaction Highlights Transaction expected to accelerate First Choice Healthcare Solutions, Inc.’s strategic rebrand to Wellgevity 360, a next-generation healthcare and wellness platform focused on...
-
MENLO PARK, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company), an eyecare technology company focused on developing and commercializing...
-
Gentherm acquires Innovative Medical Equipment, adding ThermaZone thermal therapy technology to expand its medical portfolio and growth opportunities.
-
Austin, TX, USA, July 22, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “Botulinum Toxin in Urology Market Size, Trends and Insights By Product Type...
-
New York, USA, July 22, 2026 (GLOBE NEWSWIRE) -- Global Robotic Endoscopy Devices Market is Predicted to Exhibit Remarkable Growth at a CAGR of ~10% by 2034 | DelveInsight The robotic endoscopy...
-
Revised transaction expands NexTel’s acquisition from JumpstartRx and NuevistraMed to Island 40 Group’s broader growth platform, adding health services.
-
FORESIGHT TECHNOLOGY VCT PLCLEI: 21380013CXOR8N6OD97722 July 2026 Final results31 March 2026 Foresight Technology VCT Plc, managed by Foresight Group LLP, today announces the final results for the...